Recurrence
181
22
32
67
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Research Maturity
67 completed trials (37% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.3%
6 terminated out of 181 trials
91.8%
+5.3% vs benchmark
18%
32 trials in Phase 3/4
10%
7 of 67 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 67 completed trials
Clinical Trials (181)
Study of the Impact on the Evolution of the Disease in the Medium Term of the Implementation of a System of Extended Follow-up by Telephone Interview of Patients With an Eating Disorder Organized by the Nurses of the Eating Disorder Referral Center
The Effectiveness and Safety of Body Posture in Preventing Postoperative Recurrence for Chronic Subdural Hematoma
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
Holmium Laser Versus Cold Knife Treatment in Urethral Strictures
Fecal Microbiota Transplant vs Standard Treatment for Recurrent Non-Obstructive Cholangitis
Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging
Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection
Evaluation of Outcomes of the Triathlon Hinge Knee (THK) System
Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors
Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit
Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma
Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC
Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk
xDRIVE for Florida-based Cancer Patients
A National Study Examining the Most Effective Drainage Method After Burr Hole Evacuation of Chronic Subdural Hematoma
Study of Diagnostic Performance of [18F]CTT1057 in BCR
AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)
Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-Life Depression
AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer